Difference between revisions of "ICRP Glossary"
| Line 268: | Line 268: | ||
*[[Effect Dose 50 ]] | *[[Effect Dose 50 ]] | ||
| + | |||
| + | *[[Effect modifier]] | ||
*[[Effective charge number]] | *[[Effective charge number]] | ||
| Line 278: | Line 280: | ||
*[[Electrophysiology]] | *[[Electrophysiology]] | ||
| + | |||
| + | *[[Elemental dose]] | ||
*[[Emergency]] | *[[Emergency]] | ||
| Line 290: | Line 294: | ||
*[[Endogeneous excretion]] | *[[Endogeneous excretion]] | ||
| + | |||
| + | *[[Epigenetic effects]] | ||
*[[Environmental exposure]] | *[[Environmental exposure]] | ||
| Line 304: | Line 310: | ||
*[[Ethics]] | *[[Ethics]] | ||
| + | |||
| + | *[[Excess absolute risk]] | ||
| + | |||
| + | *[[Excess lifetime risk]] | ||
| + | |||
| + | *[[Excess relative risk]] | ||
*[[Excretion rate (instantaneous)]] | *[[Excretion rate (instantaneous)]] | ||
| Line 346: | Line 358: | ||
*[[Gastrointestinal syndrome]] | *[[Gastrointestinal syndrome]] | ||
| + | |||
| + | *[[Genomic integrity]] | ||
*[[Graded approach]] | *[[Graded approach]] | ||
| Line 370: | Line 384: | ||
*[[Heliosphere]] | *[[Heliosphere]] | ||
| + | |||
| + | *[[Hereditary effect]] | ||
*[[Hierarchical tissues]] | *[[Hierarchical tissues]] | ||
*[[High level waste]] | *[[High level waste]] | ||
| + | |||
| + | *[[Homologous recombination]] | ||
*[[Hormones]] | *[[Hormones]] | ||
| Line 390: | Line 408: | ||
*[[In vivo radiobioassay]] | *[[In vivo radiobioassay]] | ||
| + | |||
| + | *[[Incidence]] | ||
*[[Incident]] | *[[Incident]] | ||
| Line 400: | Line 420: | ||
*[[Individual-related]] | *[[Individual-related]] | ||
| + | |||
| + | *[[Induced genomic instability]] | ||
*[[Informed Consent]] | *[[Informed Consent]] | ||
| Line 441: | Line 463: | ||
=== <big><span id="L">L</span></big> === | === <big><span id="L">L</span></big> === | ||
| + | *[[Late normal tissue responses]] | ||
*[[Latent time/period or latency interval]] | *[[Latent time/period or latency interval]] | ||
| + | |||
| + | *[[LD<sub>50/30</sub>]] | ||
| + | |||
| + | *[[Life Span Study]] | ||
| + | |||
| + | *[[Lifetime risk]] | ||
| + | |||
| + | *[[Lifetime risk estimate]] | ||
*[[Limitation of dose]] | *[[Limitation of dose]] | ||
*[[Lineal energy]] | *[[Lineal energy]] | ||
| + | |||
| + | *[[Linear dose response]] | ||
*[[Linear-non-threshold model]] | *[[Linear-non-threshold model]] | ||
| + | |||
| + | *[[Linear-quadratic dose response]] | ||
| + | |||
| + | *[[Loss of Life Expectancy]] | ||
*[[Low Earth orbit]] | *[[Low Earth orbit]] | ||
| + | |||
| + | *[[Low dose]] | ||
| + | |||
| + | [[Low dose rate]] | ||
*[[Low level waste]] | *[[Low level waste]] | ||
Revision as of 20:06, 24 February 2021
The ICRP Glossary collects ICRP’s definitive explanations of terms for current use. It is a living document, updated regularly. Each entry shows the date it was last updated, and some include past glossary entries to help readers better understand the term in a particular context.
Many ICRP publications have included their own glossaries. The ICRP Glossary includes most of the terms in these other glossaries, many with updated entries. ICRP publications will continue to have their own glossaries when necessary, for example for highly specialized terms relevant to a single publication or helpful for a reader to have close at hand, or when introducing a new term which would also be added to the ICRP Glossary.
Although the ICRP Glossary is not a dictionary, terms already well covered in the Oxford English Dictionary are not included here unless further explanation is needed to understand the way in which these terms are used in ICRP publications.
The ICRP Glossary shown here comprises some 400 terms. Entries for an additional approximately 400 terms are being prepared, and will be added here in due course.
| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z |
A
B
C
D
E
F
G
H
I
J
K
L
- [[LD50/30]]
